Review Article

Pharmacoeconomic Evaluation of Homeopathy: Assessing Efficacy, Economics, and Policy Perspectives

Pharmacoeconomic Evaluation of Homeopathy

Abstract

Background: This narrative review aims to explore the necessity for pharmacoeconomic studies in homeopathy, elucidating key factors and methodologies essential for conducting such assessments. In contemporary healthcare, evidence-based practices are fundamental for ensuring optimal patient outcomes and resource allocation. Essential steps for conducting pharmacoeconomic studies in homeopathy involve study design, intervention identification, comparator selection, outcome measures definition, data collection, cost analysis, effectiveness analysis, cost-effectiveness analysis, cost-benefit analysis, sensitivity analysis, reporting, and peer review. While conventional medicine undergoes rigorous pharmacoeconomic evaluations, the field of homeopathy often lacks such scrutiny. However, the importance of pharmacoeconomic studies in homeopathy is increasingly recognized, given its growing integration into modern healthcare systems. Methods: A systematic search of electronic databases (PubMed, Scopus, Web of Science) was performed to identify relevant literature using keywords such as "homeopathy," "pharmacoeconomics," and "efficacy." Articles meeting inclusion criteria were assessed for quality using established frameworks like the Consolidated Health Economic Evaluation Reporting Standards (CHEERS). Data synthesis was conducted thematically, focusing on study objectives, methodologies, findings, and conclusions. Results: Ten pharmacoeconomic studies within homeopathy were identified, demonstrating varying degrees of compliance with reporting guidelines. While most studies reported costs comprehensively, some lacked methodological transparency, particularly in analytic methods. Heterogeneity was observed in study designs and outcome measures, reflecting the complexity of economic evaluation in homeopathy. Quality of evidence varied, with some studies exhibiting robust methodologies while others had limitations. Conclusion: Based on the review, recommendations include promoting homeopathic clinics, providing policy support, adopting collaborative healthcare models, and leveraging India's homeopathic resources. Pharmacoeconomic studies in homeopathy are crucial for evaluating its economic implications compared to conventional medicine. While certain studies demonstrated methodological rigor, opportunities exist for enhancing consistency, transparency, and quality in economic evaluations. Addressing these challenges is essential for informing decision-making regarding the economic aspects of homeopathic interventions.

Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada). 2021 Jan-Mar;19(1):2302. doi: 10.18549/PharmPract.2021.1.2302. Epub 2021 Feb 22. PMID: 33727994; PMCID: PMC7939117.

Abraham I, Hiligsmann M, Lee KK, Citrome L, Colombo GL, Mike Gregg. What to expect in 2024: important health economics and outcomes research (HEOR) trends. Expert Review of Pharmacoeconomics & Outcomes Research. 2023 Dec 22:1-8.

Jakovljevic M, Verhaeghe N, Souliotis K, Krstic K. Challenges of pharmacoeconomics in global health arena—Contemporary momentum in the early 2020s. Frontiers in Public Health. 2023 Apr 13;11: 1189671.

Patel N, Yanamala S, Rai M. Assessment of Extent and Quality of Pharmacoeconomic Studies in India Using Quality of Health Economic Studies Score: A Targeted Literature Review. Value in Health Regional Issues. 2024 May 1;41: 41-7.

Psenkova MB, Hlavinkova L, Visnansky M, Grega D, Ondrusova M. The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia. Value in Health Regional Issues. 2024 Jan 1;39: 14-9.

Thomas D, Hiligsmann M, John D, Al Ahdab OG, Li H. Pharmacoeconomic analyses and modeling. In: Clinical pharmacy education, practice and research. 2019 Jan 1 (pp. 261-275). Elsevier.

Ahmad A, Patel I, Parimilakrishnan S, Mohanta GP, Chung H, Chang J. The role of pharmacoeconomics in current Indian healthcare system. J Res Pharm Pract. 2013 Jan;2(1):3-9. doi: 10.4103/2279-042X.114081. PMID: 24991597; PMCID: PMC4076893.

Paulden M. A Framework for the Fair Pricing of Medicines. PharmacoEconomics. 2024 Feb;42(2):145-64.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated health economic evaluation reporting standards (CHEERS) statement. Bmj. 2013 Mar 25;346.

Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. MDM Policy & Practice. 2022 Jan;7(1):23814683211061097.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.

Leemhuis H, Seifert R. Prescriptions of homeopathic remedies at the expense of the German statutory health insurance from 1985 to 2021: scientific, legal and pharmacoeconomic analysis. Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar 2. doi: 10.1007/s00210-024-03005-x. Epub ahead of print. PMID: 38430230.

Ostermann T, Burkart J, De Jaegere S, Raak C, Simoens S. Overview and quality assessment of health economic evaluations for homeopathic therapy: an updated systematic review. Expert Rev Pharmacoecon Outcomes Res. 2024 Jan;24(1):117-142. doi: 10.1080/14737167.2023.2266136. Epub 2024 Jan 18. PMID: 37795998.

Manchanda RK, Kulhashreshtha M. Cost effectiveness and efficacy of homeopathy in primary health care units of the Government of Delhi–a study. Allgemeine Homöopathische Zeitung. 2005;250(02):33. Available at: Homeopathy Cost Effectiveness Study.

Kass B, Icke K, Witt CM, et al. Effectiveness and cost-effectiveness of treatment with additional enrollment to a homeopathic integrated care contract in Germany. BMC Health Serv Res. 2020;20:872. doi: 10.1186/s12913-020-05706-4.

Colas A, Danno K, Tabar C, Ehreth J, Duru G. Economic impact of homeopathic practice in general medicine in France. Health Econ Rev. 2015 Dec;5(1):55. doi: 10.1186/s13561-015-0055-5. PMID: 26152791; PMCID: PMC4495089.

Viksveen P, Dymitr Z, Simoens S. Economic evaluations of homeopathy: a review. Eur J Health Econ. 2014 Mar;15(2):157-74. doi: 10.1007/s10198-013-0462-7. PMID: 23397477.

Rita K, Tapas K, Afroz S, Aafiya S, Hiral B, Omkar K, Gulfisha M, Uday B. Assessment of social and economic impact of healthcare with homoeopathy for haemophilia in cognizance with patients’ perspective: a cross-sectional survey. Int J Community Med Public Health. 2023 Feb 28;10(3):1081-90. Available at: Int J Community Med Public Health Article.

Ostermann JK, Witt CM, Reinhold T. A retrospective cost-analysis of additional homeopathic treatment in Germany: Long-term economic outcomes. PLoS ONE. 2017;12(9):e0182897. doi: 10.1371/journal.pone.0182897.

Roll S, Reinhold T, Pach D, Brinkhaus B, Icke K, Staab D, Jäckel T, Wegscheider K, Willich SN, Witt CM. Comparative effectiveness of homoeopathic vs. conventional therapy in usual care of atopic eczema in children: long-term medical and economic outcomes. PLoS One. 2013 Jan 31;8(1):e54973.

Files
IssueVol 10 No 1 (2024) QRcode
SectionReview Article(s)
DOI https://doi.org/10.18502/jppm.v10i1.15399
Keywords
CHEERS Health policy Homeopathy

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Patil A, Singh S. Pharmacoeconomic Evaluation of Homeopathy: Assessing Efficacy, Economics, and Policy Perspectives. JPPM. 2024;10(1):35-46.